C07F 9/65128
Condensed with carbocyclic rings or carbocyclic ring systems
Official title: {condensed with carbocyclic rings or carbocyclic ring systems}
C07F9/65128 (Condensed with carbocyclic rings or carbocyclic ring systems) appears on 39 US grants and 52 published applications in this corpus.
Search patents in C07F- Granted patents
- 39
- Published applications
- 52
- Assignees
- 46
- Inventors
- 246
- Latest grant
- 3 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 0 | 0 |
| 1985 | 0 | 0 |
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 1 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 2 | 0 |
| 1999 | 2 | 0 |
| 2000 | 1 | 0 |
| 2001 | 0 | 0 |
| 2002 | 2 | 2 |
| 2003 | 0 | 2 |
| 2004 | 0 | 4 |
| 2005 | 0 | 3 |
| 2006 | 1 | 5 |
| 2007 | 1 | 4 |
| 2008 | 2 | 1 |
| 2009 | 2 | 2 |
| 2010 | 1 | 0 |
| 2011 | 1 | 1 |
| 2012 | 2 | 3 |
| 2013 | 1 | 1 |
| 2014 | 2 | 2 |
| 2015 | 3 | 3 |
| 2016 | 3 | 2 |
| 2017 | 1 | 2 |
| 2018 | 0 | 0 |
| 2019 | 0 | 0 |
| 2020 | 1 | 3 |
| 2021 | 0 | 0 |
| 2022 | 1 | 4 |
| 2023 | 2 | 2 |
| 2024 | 1 | 3 |
| 2025 | 0 | 2 |
| 2026 | 1 | 1 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- SOS1 inhibitor containing phosphorus3 Mar 2026US 12,565,511 B2Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Nucleoside prodrugs and uses related thereto30 Jul 2024US 12,049,474 B2Emory University
- Organic electronic device comprising an organic semiconductor layer and a device24 Oct 2023US 11,795,186 B2Novaled GmbH
- Small molecule modulators of human sting7 Feb 2023US 11,571,423 B2Curadev Pharma Limited
- Organic electronic device comprising an organic semiconductor layer15 Nov 2022US 11,502,258 B2Novaled GmbH
- Quinazoline derivatives as ectonucleotide pyrophosphatase phosphodiesterase 1 inhibitors27 Aug 2026US 2026/0250304 A1Riboscience LLC
- Tryptanthrin derivatives and uses thereof29 May 2025US 2025/0171452 A1Viscient Bio, Inc.
- ENPP1 Inhibitors and Methods of Modulating Immune Response20 Feb 2025US 2025/0059218 A1The Board of Trustees of the Leland Stanford Junior University
- Nucleoside Prodrugs and Uses Related Thereto31 Oct 2024US 2024/0360163 A1Emory University
- Sos1 inhibitor containing phosphorus1 Aug 2024US 2024/0254151 A1Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Most cited
By later US patents
- Enzymatic analysis using substrates that yield fluorescent precipitates114US 5,316,906 AMolecular Probes, Inc. · 1994
- Enzymatic analysis using substrates that yield fluorescent precipitates88US 5,443,986 AMolecular Probes, Inc. · 1995
- 3-Aryluracils having an ether (thio) carbomyloxy or sulphomyloxy substituent on the aromatic moiety66US 4,859,229 AHoffmann-La Roche Inc. · 1989
- Phosphonic ester derivatives of quinazolinones50US 5,798,344 AOtsuka Pharmaceutical Factory, Inc. · 1998
- Process for preparing quinazolin-4-one derivatives45US 5,922,866 AOtsuka Pharmaceutical Factory, Inc. · 1999